Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
48.70
-1.10 (-2.21%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bristol-Myers Squibb
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
46
47
Next >
Bristol Myers Squibb Proved in Q3 Why Its Diverse Portfolio Makes It a Solid Investment
November 14, 2023
The stock isn't nearly as risky as its low valuation suggests.
Via
The Motley Fool
Debt-Fueled Buybacks: 3 Stocks Undeterred by Rising Rates
November 13, 2023
Share repurchases have slowed in 2023, partly due to the 1% tax. Here are three buybacks partially paid for with debt offerings.
Via
InvestorPlace
Merck and Bristol Myers Squibb Will Face Off in This 1 Market -- but Who Will Win?
November 11, 2023
There's a lot more at stake than bragging rights.
Via
The Motley Fool
Decoding Bristol-Myers Squibb's Options Activity: What's the Big Picture?
November 09, 2023
Via
Benzinga
3 No-Brainer Stocks to Buy With $500 Right Now
November 08, 2023
A reasonably modest amount of money can go a long way when it's invested in time-tested businesses with sustained catalysts.
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via
Benzinga
Looking At Bristol-Myers Squibb's Recent Unusual Options Activity
October 30, 2023
Via
Benzinga
Is NYSE:BMY suited for dividend investing?
October 30, 2023
Is BRISTOL-MYERS SQUIBB CO (NYSE:BMY) suited for dividend investing?
Via
Chartmill
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Christopher Boerner To Take The Helm At Bristol Myers Squibb As Chair Of The Board, CEO
October 31, 2023
Via
Benzinga
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
October 28, 2023
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its...
Via
Talk Markets
Pharma Giant Bristol-Myers Stock At 52-Week Low: Analyst Sees Uncertainty In Near-Term Outlook
October 27, 2023
Bristol-Myers Squibb Co (NYSE: BMY) shares are trading lower on continuous weakness following the disappointing Q3 earnings and a downward revision to the
Via
Benzinga
Bristol Myers Squibb Analysts Slash Their Forecasts Following Q3 Results
October 27, 2023
Bristol Myers Squibb & Co (NYSE: BMY) reported better-than-expected earnings for its third quarter.
Via
Benzinga
Stock Market Correction Intensifies; Google, Meta, Microsoft, Amazon Are Big Earnings Movers: Weekly Review
October 27, 2023
Microsoft, Google, Amazon and Meta led big earnings.
Via
Investor's Business Daily
Why LianBio Stock Is Skyrocketing Today
October 24, 2023
Investors are loving LianBio's new deal with Bristol Myers Squibb.
Via
The Motley Fool
Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript
October 26, 2023
BMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Mixed; Bristol Myers Posts Upbeat Earnings
October 26, 2023
U.S. stocks traded mixed this morning, following the release of several economic reports. Following the market opening Thursday, the Dow traded up 0.10% to 33,069.66 while the NASDAQ fell 0.24% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Bristol Myers Squibb's Revlimid Sales Plunge 41%, but Opdivo and Eliquis Boost Q3, Stock Dips
October 26, 2023
Bristol Myers Squibb & Co (NYSE: BMY) said that its Q3 revenues of $10.966 billion declined 2% Y/Y, or 3% when adjusted for foreign exchange, due to lower sales of Revlimid, partially offset by in-line...
Via
Benzinga
Bristol Myers Skids 5% After Pushing Back A Key Sales Milestone By A Year
October 26, 2023
The company expects its new drugs to reach $10 billion in sales by 2026.
Via
Investor's Business Daily
Nasdaq Futures Plunge As Meta Warns Of Q4 Softness: GDP Data, Amazon Earnings On Investors' Radar Amid Market Mayhem
October 26, 2023
Stock futures are plunging after the mega-cap tech names haven't turned in the strong results that the markets had factored in.
Via
Benzinga
2 Absurdly Cheap Healthcare Stocks to Buy and Hold for Decades
October 26, 2023
You won't have to worry about paying a premium for either one of these stocks -- and they both pay a solid dividend.
Via
The Motley Fool
Meta, Amazon And 3 Stocks To Watch Heading Into Thursday
October 26, 2023
With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Fear Continues To Grip Markets As S&P 500 Settles Below 4,200
October 26, 2023
The CNN Money Fear and Greed index showed growth easing in the overall fear level, remaining in the "Fear" zone on Wednesday. U.S. stocks closed lower on Wednesday, with the S&P 500 closing the session...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
META Up +4% On +23% Revenue Growth; IBM And NOW Also Beat
October 25, 2023
Markets sagged throughout the course of today’s trading session after starting mixed, with the Dow basking in Microsoft’s stellar previous-afternoon’s earnings report.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
This Artificial Intelligence (AI) Stock Is Powering the Biotech Revolution: Should You Invest?
October 25, 2023
There's more to the AI boom than Microsoft and ChatGPT.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Is LianBio (LIAN) Stock Up 130% Today?
October 24, 2023
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications.
Via
InvestorPlace
Why LianBio Stock Is Ripping Higher Today
October 24, 2023
LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and...
Via
Benzinga
'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company
October 24, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended selling Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR).
Via
Benzinga
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
The venerable pharmaceutical companies' shares have slumped this year.
Via
The Motley Fool
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
46
47
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.